Global economy is facing increasing uncertainty due to trade tensions and market volatility. US President is intensifying this instability by initiating trade wars with both allies and adversaries, using tariffs to counter what he considers unfair trade practices.US and China have already entered into economic brinksmanship over it which should result into increasing inflation and recession risks for atleast US and China.
The BSE Sensex closed at 77,414.92 gaining by 5.76% and the Nifty 50 closed at 23,519.35 gaining by 6.30% in March 2025, pausing after a six-session rally that erased their 2025 losses, as uncertainty over U.S. reciprocal import tariffs kept investors cautious. (However, At the time of writing this US Tariff wars have drained most of the gains). After heightened activity in 2024, there has been a slowdown in new listings, with no main-board IPOs hitting the market in the past three weeks due to a correction in the secondary market.
Key M&A and PE Deals include Zydus Lifesciences Limited acquiring controlling stake in French Orthopedics Firm Amplitude Surgical SA for over €256.8 million and DCDC Health Services Private Ltd (DCDC) raising Rs. 150 Crores from ABC Impact, the Asia-focused impact investor backed by Temasek. To read more, click here.
